Icandra (previously Vildagliptin / metformin hydrochloride Novartis) 欧盟 - 丹麦文 - EMA (European Medicines Agency)

icandra (previously vildagliptin / metformin hydrochloride novartis)

novartis europharm limited - vildagliptin, metformin-hydrochlorid - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 og 5. 1 for tilgængelige data på forskellige kombinationer).

Amlodipine/Valsartan/Hydrochlorothiazide "Krka" 5+160+12,5 mg filmovertrukne tabletter 丹麦 - 丹麦文 - Lægemiddelstyrelsen (Danish Medicines Agency)

amlodipine/valsartan/hydrochlorothiazide "krka" 5+160+12,5 mg filmovertrukne tabletter

krka d.d. novo mesto - amlodipinbesilat, hydrochlorthiazid, valsartan - filmovertrukne tabletter - 5+160+12,5 mg